APA (7th ed.) Citation

Kitonsa, J., Serwanga, J., Cheeseman, H. M., Abaasa, A., Lunkuse, J. F., Ruzagira, E., . . . Kaleebu, P. (2025). Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals. MDPI AG.

Chicago Style (17th ed.) Citation

Kitonsa, Jonathan, et al. Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals. MDPI AG, 2025.

MLA (9th ed.) Citation

Kitonsa, Jonathan, et al. Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals. MDPI AG, 2025.